Lista de obras - Janis M. Miyasaki - Dominio Público Uruguay

A case of ‘circling seizures’ and an intratumoral abscess ⬇️

artículo científico publicado el 1 de abril de 2003

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

artículo científico publicado en 2008

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

artículo científico

AAN guidelines: a benefit to the neurologist

artículo científico publicado en 2010

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

artículo científico publicado en 2008

Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

artículo científico publicado en 2009

Associated movement disorders in orthostatic tremor.

artículo científico publicado en 2012

Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease

artículo científico publicado en 2018

Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism

artículo científico publicado en 2016

Burnout, career satisfaction, and well-being among US neurologists in 2016.

artículo científico publicado en 2017

Chorea caused by toxins

artículo científico publicado el 1 de enero de 2011

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

artículo científico

Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns

artículo científico publicado en 2017

Diagnosis and treatment of impulse control disorders in patients with movement disorders

artículo científico publicado en 2013

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

artículo científico publicado en 2009

Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions

artículo científico publicado en 2013

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

artículo científico publicado en 2010

Effect of GPi pallidotomy on motor function in Parkinson's disease.

artículo científico publicado en 1995

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

artículo científico publicado en 2010

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

artículo científico publicado en 2012

Evidence-based initiation of dopaminergic therapy in Parkinson's disease ⬇️

artículo científico publicado el 1 de noviembre de 2010

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

artículo científico publicado en 2012

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

artículo científico publicado en 2007

High prevalence of physical and sexual aggression to caregivers in advanced Parkinson's disease. Experience in the Palliative Care Program

artículo científico publicado en 2016

Invited article: Neurology and quality improvement: an introduction

artículo científico publicado en 2008

Leadership, Recognition Awards and Publication by Men and Women in the American Academy of Neurology

scientific article published on 15 September 2020

Letter from the Guest Editors

artículo científico publicado en 2012

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease

artículo científico publicado en 2007

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia

artículo científico publicado en 2007

Mobility, mood and site of care impact health related quality of life in Parkinson's disease

artículo científico publicado en 2013

Movement Disorders in Pregnancy

artículo científico publicado en 2014

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

artículo científico publicado en 2013

New insights into the neural basis of functional movement disorders

scientific article published on 06 July 2016

New practice parameters in Parkinson's disease

artículo científico publicado en 2006

Palliative Care in Parkinson’s Disease

artículo científico publicado en 2013

Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research

artículo científico publicado en 2017

Palliative care and neurology: time for a paradigm shift

artículo científico

Palliative care for Parkinson's disease: has the time come?

artículo científico

Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD.

artículo científico publicado en 2012

Palliative stage Parkinson’s disease: patient and family experiences of health-care services

article

Parkinson disease patients' perspectives on palliative care needs: What are they telling us?

artículo científico publicado en 2016

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

artículo científico publicado en 2006

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

artículo científico publicado en 2010

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

scientific article published on 06 September 2006

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

scientific article published on 01 June 2006

Punding prevalence in Parkinson's disease

artículo científico publicado en 2007

Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary

artículo científico publicado en 2016

Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians

artículo científico publicado en 2014

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations

artículo científico publicado en 2010

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond

artículo científico publicado en 2015

The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics

scholarly article

The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?

artículo científico publicado en 2018

Treatment of Advanced Parkinson Disease and Related Disorders

artículo científico publicado en 2016

Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: Differential effects on bradykinesia

scientific article published on 01 February 2007

Using Evidence-Based Medicine in Neurology

article

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

artículo científico publicado en 2009

What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study

artículo científico publicado en 2012

Which dyskinesia scale best detects treatment response?

artículo científico publicado en 2013

Lista de obras de Janis M. Miyasaki

A case of ‘circling seizures’ and an intratumoral abscess ⬇️

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

AAN guidelines: a benefit to the neurologist

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Associated movement disorders in orthostatic tremor.

Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease

Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism

Burnout, career satisfaction, and well-being among US neurologists in 2016.

Chorea caused by toxins

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns

Diagnosis and treatment of impulse control disorders in patients with movement disorders

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

Effect of GPi pallidotomy on motor function in Parkinson's disease.

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

Evidence-based initiation of dopaminergic therapy in Parkinson's disease ⬇️

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

High prevalence of physical and sexual aggression to caregivers in advanced Parkinson's disease. Experience in the Palliative Care Program

Invited article: Neurology and quality improvement: an introduction

Leadership, Recognition Awards and Publication by Men and Women in the American Academy of Neurology

Letter from the Guest Editors

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia

Mobility, mood and site of care impact health related quality of life in Parkinson's disease

Movement Disorders in Pregnancy

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

New insights into the neural basis of functional movement disorders

New practice parameters in Parkinson's disease

Palliative Care in Parkinson’s Disease

Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research

Palliative care and neurology: time for a paradigm shift

Palliative care for Parkinson's disease: has the time come?

Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD.

Palliative stage Parkinson’s disease: patient and family experiences of health-care services

Parkinson disease patients' perspectives on palliative care needs: What are they telling us?

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

Punding prevalence in Parkinson's disease

Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary

Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond

The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics

The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?

Treatment of Advanced Parkinson Disease and Related Disorders

Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: Differential effects on bradykinesia

Using Evidence-Based Medicine in Neurology

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study

Which dyskinesia scale best detects treatment response?